Increase of formation of methylamine and formaldehyde in vivo after administration of nicotine and the potential cytotoxicity

Neurochemical Research

Volumn 23, Issue 9, 1998, Pages 1205-1210

  Yu, Peter H ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Adrenaline; Atherosclerosis; Formaldehyde, semicarbazide sensitive amine oxidase (SSAO); Methylamine; Nicotine smoking

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); CIGARETTE SMOKE; FORMALDEHYDE; METHYLAMINE; MONOAMINE OXIDASE INHIBITOR; NICOTINE;

ADRENALIN RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; CIGARETTE SMOKING; CONTROLLED STUDY; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; URINALYSIS;

ALLYL COMPOUNDS; AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; BIOTRANSFORMATION; BUTYLAMINES; ENZYME INHIBITORS; FORMALDEHYDE; MALE; METHYLAMINES; MICE; NICOTINE; RATS; RATS, WISTAR; SMOKING; TISSUE DISTRIBUTION; TRITIUM;

ANIMALIA; NICOTIANA TABACUM;

EID: 0031902268     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020786219966     Document Type: Article

References (47)

1. Wilens, S. L., and Plair, C. M. 1962. Cigarette smoking and atherosclerosis. Science 138:975-977.
2. Sackett, D. L., and Winkelstein, W. 1967. The relationship between cigarette usage and aortic atherosclerosis. Am. J. Epidemiol. 86:264-270.
3. US Dept Health and Human Services. 1989. Reducing the health consequences of smoking; A report of the surgeon general. DHHS publication No. (CDC) 89-8411.
4. Lin, S. L., Hong, C. Y., Chang, M. S., Chiang, B. N., and Chien, S. 1992. Long-term nicotine exposure increases aortic endothelial cell and enhances transendothelial macromolecular transport in rats. Atheriosclerosis and Thromb. 12:1305-1312.
5. Auerbach, O., Hammond, E. C., and Garfinkel, L. 1965. Smoking in relation to atherosclerosis of the coronary arteries. N. Engl. J. Med. 273:775-779.
6. Strong, J. P., and Richards, M. L. 1976. Cigarette smoking and atherosclerosis in autopsied men. Atherosclerosis 23:451-476.
7. US Dept Health and Human Services. 1982. Constituents of tobacco smoke. USPHS Publication No. 82-50179322.
8. Doll, R., and Hill, A. B. 1964. Mortality in relation to smoking: Ten year's observations of British doctors. Br. Med. J. i:1460-1467.
9. Hammond, E. C. 1966. Smoking in relation to the death rates of one million men and women. In: Epidemiological approaches to the study of cancer and other chronic diseases. Natl. Cancer Inst. Momogr. 19:127-204.
10. Pirart, J. 1978. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1:168-188.
11. Gerich, J. E. 1988. Role of insulin resistance in the pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus. In: Bailliere's Clinical Endocrinology and Metabolism, Nattrass M, Halle PJ (eds), 2:307-326.
12. Epifano, L., Di Vincenzo, A., Fanelli, C., Porcellati, F., Perriello, G., De Feo, P., Motolese, M., Brunetti, P., and Bolli, C. B. 1982. Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus. Eur. J. Clin. Pharmacol. 43:257-263.
13. Magee, P. N. 1976. Montesano R., and Preussmann R., N-Nitroso compounds and related carcinogens. Am. Chem. Soc. Monogr. 173:491-625.
14. Precious, E., Gunn, C. E., and Lyles, G. A. 1988. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta. Biochem. Pharmacol. 37:707-713.
15. Lyles, G. A., Holt, A., and Marshal, C. M. S. 1990. Further studies on the metabolism of methylamine by semicarbazide-sensitive amine oxidase activities in human plasma. J. Pharm. Pharmacol. 42:322-338.
16. Yu, P. H. 1990. Oxidative deamination of aliphatic amines by rat aorta semicarbazide-sensitive amine oxidase. J. Pharm. Pharmacol. 42:882-884.
17. Boor, P., Trent, M. B., Lyles, G. A., Tao, M., and Ansari, G. A. S. 1992. Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase. Toxicology 73:251-258.
18. Blau, K. 1991. Chromatographic methods for the study of amines from biological material. Biochem. J. 80:193-200.
19. Lyles, G. A., and McDougall, S. A. 1989. The enhanced daily excretion of urinary methylamine in rats treated with semicarbazide or hydralazine may be related to the inhibition of semicarbazide-sensitive amine oxidase activities. J. Pharm. Pharmacol. 41:97-100.
20. Baba, S., Watanabe, Y., Gejy, F., and Arakwa, M. 1984. Highperformance liquid Chromatographic determination of serum aliphatic amines in chronic renal failure. Clin. Chim. Acta 136:49-56.
21. Asatoor, A. M., and Kerr, D. N. S. 1961. Amines in blood and urine in relation to liver disease. Clin. Chim. Acta 6:149-156.
22. Smith, A. D., and Jepson, J. B. 1967. Chromatography of urinary and tissue amines and amino alcohols as 2,4-dinitrophenyl derivatives prepared with 2-nitrobenzenesulfonic acid. Anal. Biochem. 18:36-45.
23. Nixon, R. 1972. Volatile amines in mouse brain: a radioassay with picogram sensitivity. Anal. Biochem. 48:460-470.
24. Schayer, R. W., Smiley, L. R., and Kaplan, H. E. 1952. The metabolism of epinephrine containing isotopic carbon. J. Biol. Chem. 198:545-551.
25. Dar, M. S., Morselli, P. L., and Bowman, E. R. 1985. The enzymatic systems involved in the mammalian metabolism of methylamine. Gen. Pharmacol. 16:557-560.
26. Zeisel, S. H., Wishnok, J. S., and Blusztjan, J. K. 1983. Formation of methylamine from ingested choline and lecithin. J. Pharmacol. Exp. Therap. 225:320-324, 1983.
27. McKennis, Jr. H., Turnbull, L. B., Schwarte, S. L., Tamake, E., and Bowman, E. R. 1962. Demethylation in the metabolism of (-)-nicotine. J. Biol. Chem. 237:541-546.
28. Bolt, H. M. 1987. Experimental toxicology of formaldehyde. J. Can. Res. Clin. Oncol. 13:305-309.
29. Grafstrom, R. C., Curren, R. D., Yang, L. L., and Harris, C. C. 1985. Genotoxicity of formaldehyde in cultured human bronchial fibroblasts. Science 228:89-91.
30. Trézl, L., Török, G., Vasvári, G., and Pipek, J. 1992. Formation of burst chemiluminescence, excited aldehydes, and singlet oxygen in model reactions and from carcinogenic compound in rat liver S9 fractions. In: Role of Formaldehyde in Biological Systems, Tyihak, E. (ed.), Hungarian Biochem. Soc., Sopron, Hungary.
31. Yu, P. H., and Zuo, D. M. 1993. Methylamine, a potential endogenous toxin for vascular tissues: formation of formaldehyde via enzymatic deamination and the cytotoxic effects on endothelial cells. Diabetes 42:594-603.
32. Yu, P. H., Lai, C. T., and Zuo, D. M. 1997. Formation of formaldehyde from adrenaline in vivo; a potential risk factor endothelial damage. Neurochem. Res. 22:615-620.
33. Yu, P. H., and Zuo, D. M. 1996. Formaldehyde produced endogenously via deamination of methylamine; a potential risk factor for initiation of endothelial injury. Atherosclerosis 120:189-197.
34. Boor, P. J., and Hysmith, R. M. 1987. Allylamine cardiovascular toxicity. Toxicology 44:129-144.
35. Cryer, P. E., Haymond, M. W., Santiago, J. V., and Shad, S. D. 1976. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated haemodynamic and metabolic events. N. Engl. J. Med. 295:573-577.
36. Yu, P. H. 1986. Monoamine Oxidase. In, Neuromethods Volume V: Neurotransmitter Enzymes (eds. Boulton, A. A., Baker, G. B. and Yu, P. H.) Humana Press, Clifton, New Jersey, pp. 235-272.
37. von Euler, U. S. 1976. Adrenal medullary secretion and its neural control. In: Martini, L. and Ganong, W. F., eds, Neuroendocrinology vol. 2, New York: Academic Press, pp 283-333.
38. Frankenhaeuser, M. 1971. Behavior and circulating catecholamines. Brain Res. 31:241-262.
39. Dahl, A. R., and Hadley, W. N. 1983. Formaldehyde production promoted by rat nasal cytochrome p-450-dependent monoxygenases with nasal decongestants, essences, solvents, air polutants, nicotine, and cocaine as substrates. Toxicol. Appl. Pharmacol. 67: 200-205.
40. Helander, A., and Tottmar, O. 1987. Metabolism of biogenic aldehydes in isolated human blood cells, platelets and in plasma. Biochem. Pharmacol. 36:1077-1082.
41. Nilsson, S. E., Tryding, N., and Tufvesson, G. 1968. Serum monoamine oxidase in diabetes mellitus and some other internal diseases. Acta Med. Scand. 184:105-108.
42. Tryding, N., Nilsson, S. E., Tufvesson, G., Berg, R., Carlstrom, S., Elmfors, B. and Nilsson, J. E. 1969. Physiological and pathological influences on serum monoamine oxidase level. Scan. J. Clin. Lab. Invest. 23:79-84.
43. Boomsma, F., Derkx, F. H. M., van den Meiracker, A. H., Veld, A. J. M., and Schalekamp, M. A. D. H. 1995. Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin. Sci. 88:675-679.
44. Hayes, B. E., and Clarke, D. E. 1990. Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats. Res. Comm. Chem. Pathol. Pharmacol. 69:71-83.
45. Elliott, J., Fowden, A. L., Callingham, B. A., Sharman, D. F., and Silver, M. 1991. Physiological and pathological influences on sheep blood plasma amine oxidase: effect of pregnancy and experimental alloxan-induced diabetes mellitus. Res. Vet. Science 50:334-339.
46. Boomsma, F., van Veldhuisen, D. J., de Kam, P. J., in't Veld, A. J. M., Mosterd, A., Lie, K. I., and Schalekamp, M. A. D. H. 1997. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc. Res. 33:387-391.
47. Wilson, P. W. F., Anderson, K. M., and Kannel, W. B. 1986. Epidemiology of diabetes mellitus in the elderly. Am. J. Med. 80(Suppl.):3-9.